Project Details
Description
A Phase II Study Testing the Safety and Activity of AGS-003 as an Immunotheapeutic in Subjects with Newly Diagnosed Advanced Stage Renal Cell Carcinoma in Combination with Sunitinib
| Status | Finished |
|---|---|
| Effective start/end date | 5/2/08 → 5/31/13 |
Funding
- ARGOS THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.